Breaking News

BioScreen Completes FDA Inspection

July 8, 2014

Inspection covered quality system and lab facilities in Torrance, CA

BioScreen Testing Services, Inc. has successfully completed an FDA audit of their lab facility in Torrance, CA, with no 483 citations issued. The inspection covered BioScreen’s quality system as well as all lab facilities, and expanded chemistry and microbiology labs. 
 
"The results from the FDA audit are extremely positive and serve as a testament to the high Quality Standards that BioScreen sets for itself," said Ranil M. Fernando, executive vice president of BioScreen.
 
BioScreen's President, Bradford Rope added, "We are extremely pleased to share this news

Related Compliance:

  • Patheon Furthers Expansion Strategy

    Kristin Brooks, Contract Pharma||January 9, 2017
    Patrick Glaser of Patheon discusses expanded manufacturing capacity, capabilities, and future plans

  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • 2015 Contracting & Outsourcing Wrap-up

    2015 Contracting & Outsourcing Wrap-up

    Kristin Brooks, Contract Pharma||September 30, 2015
    A huge success, with another year of record attendance, sold-out exhibit hall, and a great line up of informative sessions